Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in patients with Type 2 diabetes.

People take GLP-1 drugs like Wegovy, Ozempic, Mounjaro, and Zepbound for a variety of reasons, from controlling diabetes and sleep apnea to managing weight and enjoying benefits to the heart, liver, ...

Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...

Research out today might provide even more of a reason for people to stay on GLP-1 medications like semaglutide, the active ...

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other heart problems.

A comprehensive Lancet review synthesizes evidence from major clinical trials showing that GLP-1 receptor agonists and ...

Generic statins and angiotensin receptor blockers typically used for heart disease also have the potential to bolster the immune systems of patients with Ebola virus and other life-threatening ...

The new guidelines aim to give doctors and their patients an individualized and clear path to follow. Heart disease remains the leading cause of death worldwide, according to the ...

People who use drugs with anticholinergic effects, including certain antidepressants, drugs for urinary incontinence and ...

According to the World Health Organization,19.8 million people died from cardiovascular diseases in 2022. And seniors—many of ...